SAT-LB023 Elevated Fasting Plasma Glucose Predicts Higher Odds For Becoming A Super-responder With Gelesis100 In The GLOW Pivotal Weight-loss Study

Background: In a previous pilot weight-loss study, an association was observed between baseline fasting plasma glucose (FPG) levels and the effectiveness of the Gelesis100 treatment. The aim of this subanalysis of the Gelesis Loss Of Weight (GLOW; NCT02307279) study is to further assess the associat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Endocr Soc
Prif Awduron: Greenway, Frank, Fujioka, Ken, Aronne, Louis, Raben, Anne, Astrup, Arne, Matejkova, Erika, Svacina, Stepan, Luzi, Livio, Gnessi, Lucio, Apovian, Caroline, Hill, James, Kaplan, Lee, Navas-Carretero, Santiago, Martinez, J., Still, Christopher, Sannino, Alessandro, Saponaro, Cosimo, Calderon, Henry, Urban, Lorien, Chiquette, Elaine, Leider, Harry, Ron, Eyal, Zohar, Yishai, Heshmati, Hassan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Endocrine Society 2019
Pynciau:
Adipose Tissue, Appetite, and Obesity
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6552254/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-LB023
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg